The Wall Street Journal
The Wall Street Journal
@wsj·6.6M subscribers·28.7K videos

Investors Bet Ketamine Treatment Will Revolutionize Mental-Health Care | WSJ

Posted

September 12, 2022

Views

93,298

Likes

1,653

Comments

303

Engagement

2.10%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

Chapters

YouTube Description

as posted by the channel

Hundreds of clinics specializing in ketamine treatment for depression, anxiety and post-traumatic stress disorder have popped up in the U.S. in recent years. Some investors are even throwing hundreds of millions of dollars into ketamine startups. How big could the market for psychedelic treatment get?

WSJ visits one clinic, Nushama, to learn why some entrepreneurs are betting that demand for ketamine will continue to rise.

#Ketamine #MentalHealth #WSJ

Guests & Subjects Covered

America CostKetamine MentalHealth WSJ

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Investors Bet Ketamine Treatment Will Revolutionize Mental-Health Care | WSJ · The Wall Street Journal · Sentinel